Published in J Gen Virol on September 01, 1989
Gene expression during reactivation of herpes simplex virus type 1 from latency in the peripheral nervous system is different from that during lytic infection of tissue cultures. J Virol (1997) 1.86
Virus and cell RNAs expressed during Epstein-Barr virus replication. J Virol (2006) 1.80
Competitive quantitative PCR analysis of herpes simplex virus type 1 DNA and latency-associated transcript RNA in latently infected cells of the rat brain. J Virol (1994) 1.51
Mechanisms of herpes simplex virus type 1 reactivation. J Virol (1996) 1.49
Neither LAT nor open reading frame P mutations increase expression of spliced or intron-containing ICP0 transcripts in mouse ganglia latently infected with herpes simplex virus. J Virol (2002) 1.46
PCR-based analysis of herpes simplex virus type 1 latency in the rat trigeminal ganglion established with a ribonucleotide reductase-deficient mutant. J Virol (1994) 1.45
Two herpes simplex virus type 1 latency-active promoters differ in their contributions to latency-associated transcript expression during lytic and latent infections. J Virol (1995) 1.37
Characterization of herpes simplex virus type 2 transcription during latent infection of mouse trigeminal ganglia. J Virol (1990) 1.34
Evidence for herpes simplex viral latency in the human cornea. Br J Ophthalmol (1991) 1.27
Herpes simplex virus type 1 ICP0 protein does not accumulate in the nucleus of primary neurons in culture. J Virol (2000) 1.20
Attenuated, replication-competent herpes simplex virus type 1 mutant G207: safety evaluation in mice. J Virol (2000) 1.05
Latency-associated transcripts in corneas and ganglia of HSV-1 infected rabbits. Br J Ophthalmol (1991) 0.92
Osteogenic protein-1 (bone morphogenetic protein-7) in the treatment of tibial nonunions. J Bone Joint Surg Am (2001) 5.13
Acute and recurrent infection with herpes simplex virus in the mouse: a model for studying latency and recurrent disease. J Gen Virol (1975) 4.39
The polymerase chain reaction: a new epidemiological tool for investigating cervical human papillomavirus infection. BMJ (1989) 3.43
Biochemical transformation of mouse cells by fragments of herpes simplex virus DNA. Cell (1977) 3.38
Interactions of TRIC agents with macrophages and BHK-21 cells observed by electron microscopy. J Hyg (Lond) (1973) 2.85
Cultivation of TRIC agents: a comparison between the use of BHK-21 and irradiated McCoy cells. J Hyg (Lond) (1974) 2.66
Identification and isolation of human prostate epithelial stem cells based on alpha(2)beta(1)-integrin expression. J Cell Sci (2001) 2.64
Predisposing gene for early-onset prostate cancer, localized on chromosome 1q42.2-43. Am J Hum Genet (1998) 2.59
HPV 16 DNA in normal and malignant cervical epithelium: implications for the aetiology and behaviour of cervical neoplasia. Lancet (1987) 2.38
Efficacy of treatment of MS with IFNbeta-1b or glatiramer acetate by monthly brain MRI in the BECOME study. Neurology (2009) 2.36
Correlation between p53 mutations and antibody staining in breast carcinoma. Br J Surg (1993) 2.09
Immune cell infiltration and persistence in the mouse trigeminal ganglion after infection of the cornea with herpes simplex virus type 1. J Neuroimmunol (1995) 1.89
No eye pad for corneal abrasion. Eye (Lond) (1993) 1.85
Effects of bone mineral density on pedicle screw fixation. Spine (Phila Pa 1976) (1994) 1.83
Quantitative functional measures in MS: what is a reliable change? Neurology (2002) 1.81
Lumbar spine and femoral neck bone mineral density in idiopathic scoliosis: a follow-up study. J Pediatr Orthop (1992) 1.75
Circulating demyelinating factors in acute idiopathic polyneuropathy. Arch Neurol (1971) 1.74
Precise microdissection of human prostate cancers reveals genotypic heterogeneity. Cancer Res (1998) 1.74
Age-related decline in proprioception. Clin Orthop Relat Res (1984) 1.70
Serologic evidence of previous Campylobacter jejuni infection in patients with the Guillain-Barré syndrome. Ann Intern Med (1993) 1.69
Landry-Guillain-Barré syndrome. A primary demyelinating disease. Arch Neurol (1969) 1.67
The pathogenesis of pseudorabies in mice following peripheral inoculation. J Gen Virol (1974) 1.64
Possible beneficial effect of high-dose intravenous steroid therapy in acute demyelinating disease and transverse myelitis. Neurology (1980) 1.62
Declining incidence of multiple sclerosis in the Orkney Islands. Neurology (1985) 1.54
Spread of virus and distribution of latent infection following ocular herpes simplex in the non-immune and immune mouse. J Gen Virol (1982) 1.52
An Investigation of Spirochetosis of the Dental Anlage in Congenital Syphilis. Am J Pathol (1931) 1.51
Acanthamoeba keratitis. Surv Ophthalmol (1998) 1.49
Reactivation of latent infection and induction of recurrent herpetic eye disease in mice. J Gen Virol (1990) 1.46
Identification of degradome components associated with prostate cancer progression by expression analysis of human prostatic tissues. Br J Cancer (2005) 1.45
Correlation between sex hormones and magnetic resonance imaging lesions in multiple sclerosis. Acta Neurol Scand (1999) 1.44
Progress in the preclinical discovery and clinical development of class I and dual class I/IV phosphoinositide 3-kinase (PI3K) inhibitors. Curr Med Chem (2011) 1.44
Interactions of TRIC agents with macrophages: effects on lysosomal enzymes of the cell. J Hyg (Lond) (1974) 1.43
Combined interrupted and continuous versus single continuous adjustable suturing in penetrating keratoplasty: a prospective, randomized study of induced astigmatism during the first postoperative year. Ophthalmology (1998) 1.43
Immunohistochemical detection of T-cell subsets and other leukocytes in paraffin-embedded rat and mouse tissues with monoclonal antibodies. J Histochem Cytochem (1995) 1.43
Human papillomavirus type-16 homologous DNA in normal human ectocervix. Lancet (1986) 1.42
The effect of osteogenic protein-1 on the healing of segmental bone defects treated with autograft or allograft bone. J Bone Joint Surg Am (2001) 1.42
Effect of articular disease and total knee arthroplasty on knee joint-position sense. J Neurophysiol (1983) 1.41
Femoral neck and lumbar spine bone mineral densities in a normal population 3-20 years of age. J Pediatr Orthop (1991) 1.40
Immunogenicity of experimental trachoma vaccines in baboons. I. Experimental methods, and preliminary tests with vaccines prepared in chick embryos and in HeLa cells. J Hyg (Lond) (1966) 1.40
The detection of DNA tumour virus-specific RNA sequences in abnormal human cervical biopsies by in situ hybridization. J Gen Virol (1981) 1.38
Prostate epithelial cell lines form spheroids with evidence of glandular differentiation in three-dimensional Matrigel cultures. Br J Cancer (2001) 1.38
Some consequences of the multiple infection of cell cultures by TRIC organisms. J Hyg (Lond) (1972) 1.36
Acanthamoeba keratitis: risk factors and outcome. Br J Ophthalmol (1995) 1.36
A survey of running injuries in 1505 competitive and recreational runners. J Sports Med Phys Fitness (1990) 1.35
Detection of latent virus mRNA in tissues using the polymerase chain reaction. J Pathol (1989) 1.33
Trachoma vaccine field trials in The Gambia. J Hyg (Lond) (1969) 1.33
Recurrent herpes simplex in the mouse: inflammation in the skin and activation of virus in the ganglia following peripheral stimulation. J Gen Virol (1983) 1.31
Neutralization of TRIC organisms by antibody: enhancement by antisera prepared against immunoglobulins. J Hyg (Lond) (1974) 1.31
Structure of the intact transactivation domain of the human papillomavirus E2 protein. Nature (2000) 1.30
Canine distemper virus L gene: sequence and comparison with related viruses. Virology (1993) 1.30
Maternal allele loss in Wilms' tumour. Lancet (1989) 1.29
Acute and recurrent herpes simplex in several strains of mice. J Gen Virol (1981) 1.28
An alternative theory of herpes-simplex recurrence and a possible role for prostaglandins. Lancet (1976) 1.28
Reactivation of herpes simplex virus type 1 in the mouse trigeminal ganglion: an in vivo study of virus antigen and immune cell infiltration. J Gen Virol (1996) 1.27
Cytokine production in the nervous system of mice during acute and latent infection with herpes simplex virus type 1. J Gen Virol (1997) 1.25
Sequence variability and function of measles virus 3' and 5' ends and intercistronic regions. Virology (1988) 1.25
Cutaneous warts in butchers. Br J Dermatol (1994) 1.24
Intra-axonal location of herpes simplex virus particles. J Gen Virol (1972) 1.24
Corneal transplantation: how successful are we? Br J Ophthalmol (2000) 1.21
Co-ordinated changes in expression of cell adhesion molecules in prostate cancer. Eur J Cancer (1997) 1.21
Guillain-Barré syndrome in Greater New York-New Jersey. JAMA (1977) 1.20
Reactivation of herpes simplex virus infection by ultraviolet light and possible involvement of prostaglandins. J Gen Virol (1976) 1.20
The behaviour of human oral squamous cell carcinoma in cell culture. J Pathol (1990) 1.19
Restriction endonuclease analysis of DNA from genital isolates of herpes simplex virus type 2. Infect Immun (1982) 1.19
Trabecular bone mineral density in idiopathic scoliosis. J Pediatr Orthop (1987) 1.19
The pathogenesis of pseudorabies in mice: virus replication at the inoculation site and axonal uptake. J Gen Virol (1975) 1.19
Reactivation of herpes simplex virus type 1 in the mouse trigeminal ganglion: an in vivo study of virus antigen and cytokines. J Virol (1999) 1.18
Effect of acyclovir on recurrence of herpes simplex skin lesions in mice. J Gen Virol (1980) 1.18
Trauma to the skin causes recurrence of herpes simplex in the mouse. J Gen Virol (1978) 1.17
Ocular infection with herpes simplex virus in nonimmune and immune mice. Arch Ophthalmol (1983) 1.16
Joint position sense in total knee arthroplasty. J Orthop Res (1984) 1.16
A biomechanical analysis of the etiology of tibia vara. J Pediatr Orthop (1983) 1.15
Passive immunization protects the mouse eye from damage after herpes simplex virus infection by limiting spread of virus in the nervous system. J Gen Virol (1990) 1.14
Canine distemper terminal and intergenic non-protein coding nucleotide sequences: completion of the entire CDV genome sequence. Virology (1993) 1.14
Latent herpes simplex virus type 1 in normal and Alzheimer's disease brains. J Med Virol (1991) 1.13
Pathogenesis of zosteriform spread of herpes simplex virus in the mouse. J Gen Virol (1984) 1.13
Topographic analysis in pellucid marginal corneal degeneration and keratoglobus. Eye (Lond) (1996) 1.13
In vitro modelling of epithelial and stromal interactions in non-malignant and malignant prostates. Br J Cancer (2000) 1.11
Isolation of herpes simplex virus from the skin of clinically normal mice during latent infection. J Gen Virol (1980) 1.11
The effect of DNA hypomethylating agents on the reactivation of herpes simplex virus from latently infected mouse ganglia in vitro. Brief report. Arch Virol (1987) 1.11
the role of autoantibody and immune complexes in the pathogenesis of Guillain-Barré syndrome. Ann Neurol (1981) 1.11
Butchers' warts: no evidence for person to person transmission of HPV7. Br J Dermatol (1994) 1.11
Multiple sclerosis and viruses: an overview. Neurology (1980) 1.10
Complications related to modularity of total hip components. J Bone Joint Surg Br (1993) 1.10